Skip to end of metadata
Go to start of metadata
Date

  

Chair
StatusComplete
Comments

Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number: https://zoom.us/u/aLIcTlITh

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Attendees

Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
NameOrganizationPresent
Danielle BancroftBest Practice Software
Melva Peters (Scribe)Jenaker Consulting
Jean Duteau (Chair)Duteau Designx
John HatemIndependent Consultantx
Scott Robertson Kaiser Permanentex
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Smile Digital Health

x

Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDP
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealand
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborative
Stephen ChuADHAx
Tim McNeilSurescriptsx
Kim RobertsPharmacy HIT Collaborative
Phung Matthews3M
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna
James Tcheng

Peter Muir

Joe KellySurescripts
Peter Jordan

Jose Costa Teixeira

Jeff ShickUSP
Kent BulzaArterax

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

Project Proposals

Project Proposals in Review - none to review

Project Scope Statements

Project Scope Statements - none to review

External Meeting Review

Catalog Updates (John Hatem)

  • - No meeting

Workflow Update (John Hatem)

  • Workflow call this week

Healthcare Product Update (John Hatem)

  •  
    • Scope and Use issues.  nothing 
    • BDP Dispense (biologically derived product).  May/should look at MedicationDispense structures 
      • need to look at scope and usage for BDP
      • John H advised to keep all BDP in BCP resource(s) as there are Medication-related resources elements that don't apply to BDP

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

  •   Final document out for approval.  Wait to hear next steps.

Potential Drug-Drug Interaction (PDDI) CDS IG

NCPDP Updates (NCPDP Members)

Projects

Pharmacist Consult Note (Scott)

  • - almost done

Pharmacy Templates

  • Giorgio has a block vote, need to schedule

Specialty Medication Enrolment IG

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

Any Other Business

  • discussion on MedicationAdministration.performer.device.  who set the parameters, when set, when changed.
    • Stephen will follow up with Orders

Next meeting: